| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 08/28/2008 | US20080207712 Thiazole-amine compounds for the treatment of neurodegenerative disorders |
| 08/28/2008 | US20080207708 Analgesics; antiinflammatory agents; bone disorders; neurodegenerative diseases |
| 08/28/2008 | US20080207698 Novel Compounds 569 |
| 08/28/2008 | US20080207636 Using a benzmide compound; antidiabetic agents; obesity |
| 08/28/2008 | US20080207620 Modulators of pharmacokinetic properties of therapeutics |
| 08/28/2008 | US20080206886 Large stoke shift dye used for optical imaging |
| 08/28/2008 | CA2678907A1 Modulators of pharmacokinetic properties of therapeutics |
| 08/28/2008 | CA2677706A1 Compounds and methods for modulating g protein-coupled receptors |
| 08/27/2008 | EP1960379A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides |
| 08/27/2008 | EP1960369A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests |
| 08/27/2008 | EP1959946A2 Methods of treating ischemic related conditions |
| 08/27/2008 | EP1959944A1 A pharmaceutical composition comprising an amide derivative |
| 08/27/2008 | EP1606275B1 Opioid receptor antagonists |
| 08/27/2008 | EP1531814B1 Sustained-release tablet composition of pramipexole |
| 08/27/2008 | EP1349858B1 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
| 08/27/2008 | CN101250165A Insecticidal bis-heterocyclic compounds |
| 08/27/2008 | CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same |
| 08/26/2008 | US7417150 Azoles having an insecticidal action |
| 08/26/2008 | US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole |
| 08/26/2008 | US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 08/26/2008 | US7417030 Thrombolytic agents, restenosis, hypotension agents, heart failure, antiarrhythmia and -inflammation agents, angina, stroke, atherosclerosis, antiischemic agents, angiogenesis related disorders, anti carcinogenic and -tumor agents |
| 08/21/2008 | WO2008100564A1 Lta4h modulators and uses therof |
| 08/21/2008 | WO2008099907A1 Therapeutic agent for urinary excretion disorder |
| 08/21/2008 | WO2008098851A1 Electroluminescent metal complex |
| 08/21/2008 | WO2008075184A3 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them |
| 08/21/2008 | WO2007045962A3 Novel hdac inhibitors |
| 08/21/2008 | US20080200551 Flourene Derivative |
| 08/21/2008 | US20080200525 Pesticidally active ketone and oxime derivatives |
| 08/21/2008 | US20080200518 insecticides, acaricides; crops, foods and goods; a urea, a thiourea or a guanidine; ring is imidazole or 1,2,4-triazole or tetrazole; 4-{4-[4-(3,3-Dichloroprop-2-enyloxy)-2,6-dichlorophenoxy]butyl}-1-[4-(trifluoromethyl)phenyl]-1,2,4-triazolin-5-one; a 1,2,3,4-tetrazolin-5-one |
| 08/21/2008 | US20080200470 serotonin 5-HT1A receptor agonists; N-heterocyclclediones substituted with a chroman-2-yl, 2-quinolyl, or phenoxy group; 2-[4-[(Chroman-2-yl)methylamino]butyl]-1,3-dioxoperhydroimidazo[1,5-a]pyridine; Parkinson's, cerebral damage by thromboembolitic ictus, depression, migraine, psychosis, urinary disorde |
| 08/21/2008 | US20080200463 N-[5-(5-formyl-2-thienyl)-4-methyl-1,3-thiazol-2-yl]acetamide; autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer |
| 08/21/2008 | US20080200371 Thiazole and thiadiazole inhibitors of tyrosine phosphatases |
| 08/21/2008 | US20080196180 azo dyes for dyeing paper; colour strength, luminance and substantivity; nontoxic |
| 08/21/2008 | CA2677769A1 Therapeutic agent for urinary excretion disorder |
| 08/20/2008 | EP1957471A1 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as 2 adrenoceptor agonists |
| 08/20/2008 | EP1957461A1 Bisamide inhibitors of hedgehog signaling |
| 08/20/2008 | EP1957459A2 Iminopropene compound and use thereof |
| 08/20/2008 | EP1957448A1 Substituted azacycloalkanes useful for treating cns conditions |
| 08/20/2008 | EP1956909A1 Microbiocides |
| 08/20/2008 | EP1828152B1 Heterocyclic compounds as inhibitors of factor viia |
| 08/20/2008 | EP1660492B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/20/2008 | EP1482935B1 Thiazole and oxazole derivatives which modulate ppar activity |
| 08/20/2008 | EP1249233B1 Npyy5 antagonists |
| 08/20/2008 | CN101248054A Thiazole derivatives and use thereof |
| 08/20/2008 | CN101245052A Method for extracting benzothiazole with by-product for producing 2-mercaptobenzothiazole |
| 08/20/2008 | CN101244062A Sustained release pharmaceutical compositions and methods of treatment using the same |
| 08/20/2008 | CN100412067C Process for synthesizing chiral thiazolidine-2-thioketone |
| 08/19/2008 | US7414137 useful in the synthesis and manufacture of compounds (such as latrunculins and/or their analogs) for treating diseases or conditions associated with inhibiting actin polymerization |
| 08/19/2008 | US7414067 Ophthalmic compositions for treating ocular hypertension |
| 08/19/2008 | US7414056 Cytokine inflammatory response suppressors; mitogen activated protein 38 kinases |
| 08/19/2008 | US7414040 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia |
| 08/19/2008 | US7413536 Substrates and screening methods for transport proteins |
| 08/14/2008 | WO2008097203A1 Novel process for synthesis of pramipexole and its pharmaceutically acceptable salts |
| 08/14/2008 | WO2008096127A2 Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators |
| 08/14/2008 | WO2008096119A1 Salts 669 |
| 08/14/2008 | WO2008096112A1 Salts 668 |
| 08/14/2008 | WO2008096093A1 Oxazole and thiazole derivatives and their uses |
| 08/14/2008 | WO2008079610A3 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 08/14/2008 | WO2008019292A3 Compositions and methods for potentiating antibiotic activity |
| 08/14/2008 | WO2007109786A3 Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones |
| 08/14/2008 | US20080194832 S-enantiomer is pramipexole; reaction with an optically pure chiral di-p-toluyl tartaric acid to form the acid salt; crystallization |
| 08/14/2008 | US20080194564 the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and processes for the preparation of these |
| 08/14/2008 | US20080194465 Cross-linked glycopeptide-cephalosporin antibiotics |
| 08/14/2008 | US20080194464 Chemical intermediate thereto; effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 08/14/2008 | US20080193700 Metal Chelates and Their Use in Optical Recording Media Having High Storage Capacity |
| 08/14/2008 | CA2675994A1 Salts 668 |
| 08/13/2008 | EP1956015A2 Polymorph of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same |
| 08/13/2008 | EP1956014A2 Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same |
| 08/13/2008 | EP1956013A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 08/13/2008 | EP1956012A1 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue |
| 08/13/2008 | EP1955697A1 2-aminobenzamide derivative |
| 08/13/2008 | EP1954696A2 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 08/13/2008 | EP1954681A2 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 08/13/2008 | EP1954674A1 New n-phenethylcarboxamide derivatives |
| 08/13/2008 | EP1954132A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 08/13/2008 | EP1828177B1 Novel mch receptor antagonists |
| 08/13/2008 | EP1590337B1 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors |
| 08/13/2008 | EP1452528B1 Xanthine oxidase inhibitors |
| 08/13/2008 | CN101239956A Method for preparing (R)-4-carboxyl acid thiazoline |
| 08/13/2008 | CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/13/2008 | CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 08/13/2008 | CN100409844C Noval compound, its synthetizing process and therapeutic use |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411071 Bridged tricyclic (e.g., 9,10-ethanoanthracene) derivatives of (2-carbonylamino)thiazol-5-yloxoacetamides; diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity including obesity, diabetes, inflammatory and immune diseases |
| 08/12/2008 | US7411065 Peptide nucleic acid monomers: diphenylmethyl, benzyl, alkylthioalkyl, or phenylthioalkyl esters of N-(1-[4-(2-benzothiazolyl-, 2-benzoxazolyl-, 2-benzofuranyl- or 2-benzothiophenyl-sulfonyl)-3-piperazinon-1-ylcarbonylmethyl]pyrimidon-4-yl)carbamic acids |
| 08/12/2008 | US7410999 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 08/12/2008 | US7410988 2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 08/12/2008 | US7410987 Treating pruritus or pain, particularly that caused by a rheumatic disease, by administering a 2-[o-(aminoalkoxy)phenyl])-3-acylbenzothiazoline, e.g., 3-Acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)-propoxy)-5-methoxyphenyl]benzothiazoline |
| 08/12/2008 | US7410982 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride |
| 08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
| 08/07/2008 | WO2008036642A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 08/07/2008 | WO2008030266A3 Insecticidal n-substituted (heteroaryl)alkyl sulfilmines |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist; |
| 08/07/2008 | US20080188489 Cell differentiation inducer |
| 08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
| 08/06/2008 | EP1951696A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/06/2008 | EP1951695A1 CATALYZED PROCESS OF MAKING C-5-SUBSTITUTED HETEROCYCLIC INHIBITORS OF 11ß-HYDROXY STEROID DEHYDROGENASE TYPE 1 |
| 08/06/2008 | EP1951692A1 Oxazole and thiazole ppar modulator |
| 08/06/2008 | EP1951690A1 Heterocyclic cetp inhibitors |